MT Newswires
XOMA Royalty Amends Takeda Deal, Expects Royalties Tied to Broader Asset Portfolio
➖
AI Sentiment
Neutral
5/10
Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of) News
Latest updates and market news for TAK
3 news
Dec 26 - Jan 1, 2026
Page 1
GlobeNewswire
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
➖
AI Sentiment
Neutral
4/10
ACCESS Newswire
Blending Data and Local Knowledge To Enable Sustainable Outcomes
📊
AI Sentiment
Positive
7/10
Share this news page